InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
-23.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Butler John P., Chairman & CEO. Officer active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 19 disclosures have been published. Split: 1 buy · 7 sells. Total volume traded: €441k. History available since 3 August 2021. The latest transaction was filed on 6 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Butler John P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
350,000 shares@ US$0.630.087% mcap30.2% of flowCommon StockSEC:0001591467-26-000004:0
69,270 shares@ US$1.2516.9% of flowCommon StockSEC:0001591467-26-000003:0
Canonical exit: 2 Jun 2026 (T+90)
46,660 shares@ US$1.3912.4% of flowCommon StockSEC:0001591467-26-000002:0
743,000 shares0Common StockSEC:0001591467-26-000001:0
46,409 shares@ US$1.8326.1% of flowCommon StockSEC:0001562180-25-001998:0
701,000 shares0Common StockSEC:0001562180-25-000917:0
46,570 shares@ US$1.5821.8% of flowCommon StockSEC:0001562180-24-002021:0
37,733 shares@ US$1.5216.9% of flowCommon StockSEC:0001562180-24-001992:0
603,500 shares0Common StockSEC:0001562180-24-000971:0
32,941 sharesCommon StockSEC:0001140361-23-047727:0
47,824 shares0Common StockSEC:0001062993-23-013664:0
38,259 shares@ US$0.877510.2% of flowCommon StockSEC:0001562180-23-002201:0
38,632 shares@ US$0.81329.5% of flowCommon StockSEC:0001562180-23-002041:0
293,125 shares0Common StockSEC:0001562180-23-000832:0
23,109 shares0Common StockSEC:0001062993-22-015037:0
25,053 shares@ US$2.154810.9% of flowCommon StockSEC:0001562180-22-002166:0
1,248 sharesCommon StockSEC:0001562180-22-001654:0
5,000 shares0Common StockSEC:0001192482-21-000646:0
25,000 sharesCommon StockSEC:0001209191-16-092030:0
19 of 19 declarations
About Butler John P.
Butler John P. is Président-Directeur Général. He is linked to Akebia Therapeutics, Inc. as CEO and President, and to Zynerba Pharmaceuticals, Inc. as Director. His record includes 18 filings, and across the sampled recent filings the amounts shown are EUR 74566 of buys and EUR 366818 of sells, with transactions ranging from 2016-01-19 to 2026-03-05.
